We fixed the #IT ! So here is this week’s #ThoracicThursday #SCE style quiz question, in honour of #pulmonaryrehabweek & #BTSSummer2023 - send us your answer before the explanation at the weekend #RespEd #RespIsBest

Ray Ramon - Dangerous (Official Video) youtu.be/EX2oGZV1K7k via YouTube

Mechanisms & characteristic pathological features of #asthma immunopathology. Features are divided into eosinophilic (allergic/non-allergic), non-eosinophilic & mixed granulocytic inflammation.
blue = licensed therapies (Source: onlinelibrary.wiley.com/doi/full/10.11…)
#RespEd #biologics

Crónicas de la Ciudad Perdida The Cure! 😅

NHS England The BMJ Cochrane CochraneAirways ERS publications American Thoracic JAMA NICE British Thoracic Society (BTS) The #PR quality standards are an excellent read! brit-thoracic.org.uk/quality-improv… 15/n #RespEd

The countdown in on until answers are out! Squeeze in your answer quick! #RespEd #RespIsBest #pharmacology

Q36 was on the many benefits of #pulmonaryrehab #PR #exercise #RespEd

Booking is now open for the BTS Winter Meeting 2023. For further information on this year's programme or to book your place, see the BTS website bit.ly/BTSWinterMeeti….
#respiratory #BTSWinter2023 #RespEd #RespIsBest

Summer’s over! Get booking for Winter! #RespIsBest #RespEd

Have you committed to an answer to this week’s #ThoracicThursday #SCE style #RespEd quiz question? No? Get on it! Answer & explanation tomorrow!

NHS England The BMJ Cochrane CochraneAirways ERS publications American Thoracic JAMA Initiation of #PR is not sufficient to confer this benefit, even in this subgroup. Participants completed an average of 9 sessions, so more than 50% of the programme. 11/n #RespEd

NHS England The BMJ Cochrane CochraneAirways ERS publications American Thoracic JAMA NICE British Thoracic Society (BTS) The @nacapaudit reports are also full of useful information & QI tools & show performance against key metrics in #asthma #COPD & #PR . Plenty of room for investment & gains in helath for those with #respiratory disease nacap.org.uk/nacap/welcome.… 16/n #RespEd

NHS England In a 2019 review The BMJ set out the core components of #PR demonstrating that this is a complex intervention, caring for the whole person, & has aims far beyond increasing exercise capacity, important as this is bmj.com/content/365/bm… #RespEd 2/n

NHS England The BMJ Cochrane CochraneAirways ERS publications American Thoracic JAMA NICE British Thoracic Society (BTS) Several barriers & facilitators to accessing #PR have been identified. Limited resource is difficult to overcome, but you can provide good information, have a well co-ordinated programme & take a patient centred approach, all of which help bmchealthservres.biomedcentral.com/articles/10.11…. #RespEd 17/n

🧪 #Islam & #Science

youtu.be/L-frFO99u_4

NHS England The BMJ Cochrane CochraneAirways ERS publications American Thoracic A 2017 systematic review found only 2 relevant RCTs. 1 showed significant survival benefit at 1 year, the other nonsignificant survival benefit at 3 years. Neither were adequately powered & in both, survival was a secondary outcome. journals.sagepub.com/doi/pdf/10.117… 9/n #RespEd

Cardiopulmonary exercise testing applied to respiratory medicine: Myths and facts > #CPET is poorly understood & often under or mis-used; clinically useful strategies provided to get the most out of CPET incl exposing pulmonary limitations to exercise resmedjournal.com/article/S0954-…

Everyone’s favourite exam topic! #CPET #RespEd

A taste that will be remembered

NHS England The BMJ Cochrane CochraneAirways ERS publications American Thoracic There is no question over the positive impact of #PR on QoL, anxiety & dyspnoea, fatigue, emotional function & sense of control that individuals have over their condition. There is a question over whether #PR reduces mortality in #COPD 8/n #RespEd

It's #ThoracicThursday ! Today's #SCE style question in on pharmacology. Maybe some #respiratory pharmacists can help us out this week? Can you also identify the other drugs in the answers? As ever, answers & explanation at the weekend. #RespIsBest #RespEd

NHS England The BMJ Cochrane CochraneAirways ERS publications American Thoracic JAMA NICE British Thoracic Society (BTS) That's it for this week. We hope you learned something about #PR & will be talking to lots of patients about the benefits in your upcoming clinics & ward rounds. See you next #ThoracicThursday #RespEd 18/18

What do you think King's College Hospital Pharmacy Pharmacy Times UCL School of Pharmacy Pharmacy Podcast Network PharmacyDeclares! Peter Morgan The Respiratory ACP Network Ravijyot Saggu ? #RespEd

Lots of great answers this week. It’s a straightforward knowledge based question, but you can extend your learning by working out which Respiratory drugs the other options are. #RespEd #RespIsBest

NHS England The BMJ Cochrane CochraneAirways ERS publications American Thoracic A 2020 @jama_current retrospective cohort study of 197 376 medicare patients hospitalised with #COPD found that initiation of pulmonary rehabilitation within 90 days was associated with a lower risk of death over 1 year jamanetwork.com/journals/jama/…. 10/n #RespEd

NHS England The BMJ Cochrane CochraneAirways The ERS publications American Thoracic statement on #PR highlights the fact that PR is a high value intervention, with a cost of £2000-£8000 per QALY. This compares well to flu vaccination given that #PR is more costly & more diffucult to deliver erj.ersjournals.com/content/47/5/1… 7/n #RespEd